Association of Clinical Scientists

Introduction Downloadable, printable meeting flier

The 138^th Meeting of the Association of Clinical Scientists will be held in Houston, Texas, May 16-19, 2018. It is being hosted by the Program of Diagnostic Genetics, The University of Texas MD Anderson Cancer Center, School of Health Professions. The meeting theme will be “Genomic Medicine.” The Program Committee Co-Chairpersons, Awdhesh Kalia, PhD and Peter Hu, PhD, along with Program Committee members Robert Hunter, MD, PhD, John Hicks, MD, DDS, PhD, and Roger Bertholf, PhD cordially invite you to plan to attend another outstanding Association meeting.

Highlights:

The highlights feature two distinguished “keynote” lectures plus a distinguished banquet speaker, a Friday half day session at the MD Anderson Cancer Center, including tours of various anatomic and clinical pathology laboratories and School of Health Professions teaching laboratories, and a special optional bus tour on Friday afternoon for participants and spouses to visit the NASA Space Center Houston, which will include special tours not normally available to the general public. See the Registration Shopping Cart for more information about these special tours.

Abraham J. Gitlitz Memorial Lecture: Andy Futreal, PhD, Chair and Professor, Department of Genomic Medicine, Robert A. Welch Distinguished University Chair, the University of Texas MD Anderson Cancer Center. The title of his lecture is “Cancer Heterogeneity: Challenges and Opportunities for Clinical Impact.”

Claude P. Brown Memorial Lecture: Stanley R. Hamilton, MD, FCAP, AGAF, Professor and Head of Pathology and Laboratory Medicine at The University of Texas MD Anderson Cancer Center. His talk is entitled "The Road to Precision Oncology: Are We There Yet?"

Banquet Speaker: C Thomas Caskey, MD, FACP, FACME, FRSC, is Professor, Department of Molecular & Human Genetics-Baylor College of Medicine and Director of Precision Medicine for the Young Presidents Organization. He is past CEO of Brown Foundation Institute of Molecular Medicine at UTHSC-Houston, past senior VP, Human Genetics and Vaccines Discovery at Merck Research Laboratories, and past president, Merck Genome Institute. His talk is entitled "Precision Medicine Reduces Genetics Disease Risk."

Association Annual Awards to be Presented:

Clinical Scientist of the Year (Sunderman Award):

F.W. Sunderman Jr. Diploma of Honor:

Young Clinical Scientist:

Program

Association of Clinical Scientists 2018 Annual Meeting, Final Program (Subject to Change)
Medical Center Marriott, Houston, TX

Wednesday, May 16

2:30 – 5:30 PM	Executive Committee Meeting	Conf. Room 5
2:00 – 5:30 PM	Registration	Salons A-B Foyer
Thursday, May 17
7:00 – 5:00 PM	Registration	Salons A-B Foyer
7:00 – 8:00 AM	Membership and Mentoring Committee breakfast	Conf. Room 4
7:00 – 8:00 AM	Continental Breakfast	Salons A-D Foyer
8:00 – 8:15 AM	Opening remarks: Robert Hardy, President, ACS Peter Hu and Awdhesh Kalia, Program Committee Co-chairs	Salons A-D
8:15 – 9:00 AM	Abraham J. Gitlitz Memorial Lecture Andy Futreal – University of Texas MD Anderson Cancer Center, Cancer heterogeneity: challenges and opportunities for clinical impact	Salons A-D
Scientific Session 1: Genomic Medicine (Oncology)		Salons A-D
Moderators:	Keri Donaldson/Kyle Kurek
9:00 – 9:20 AM	Karina Eterovic – University of Texas MD Anderson Cancer Center, genomic profiling of solid tumors and cell free DNA: research and clinical aspects
9:20 – 9:40 AM	Marco Leung – University of Chicago, Clinical genetics testing reveals DDX41 as the most common gene predisposed to hereditary myeloid malignancies
9:40 – 10:00 AM	Courtney Dinardo – University of Texas MD Anderson Cancer Center, Awareness and identification of inherited predispositions to hematologic malignancies
10:00 – 10:30 AM	Morning Break	Salons E-G
Scientific Session II: Microbiome in Health and Disease
Moderators:	Irene Newsham/Casey Schroeder
10:30 – 11:00 AM	Ruth Ann Luna – Texas Children’s Hospital/Baylor College of Medicine, Gut feeling: the clinical utility of GI microbiome characterization
11:00 – 11:30 AM	Jessica Galloway-Peña– University of Texas MD Anderson Cancer Center, Clinical implications of the microbiome in the oncology patients
11:30 – 12:00 PM	Sridevi Devaraj– Texas Childrens Hospital/Baylor College of Medicine, Obesity, metabolic syndrome and the microbiome – A gut feeling
12:00 – 1:30 PM	Lunch Break: (Lunch Provided)	Salons A-D
	Samuel Shelburne – Texas Childrens Hospital/Baylor College of Medicine, Insights into infectious disease generated by genomic approaches: lessons from the front lines
Scientific Session III: Genomic and Evidenced-Based Medicine		Salons A-D
Moderators:	Rob Hardy/Karina Eterovic
1:30 – 1:45 PM	Jacquelyn Reuther – Texas Children's Hospital/Baylor College of Medicine, Clinical implication of targeted RNA sequencing for detecting fusion in solid tumors
1:45 – 2:00 PM	Diana Morlote – University of Alabama at Birmingham Molecular and cytogenetic characterization of therapy – related myeloid neoplasms: a tertiary center experience
2:00 – 2:15 PM	Roland Valdes – University of Louisville, Polypharmacy: A healthcare problem with a genomic medicine solution
2:15 – 2:30 PM	Brette Hannigan – University of Texas MD Anderson Cancer Center, Clinical validation of droplet digital PCR to detect JAK2 p.V167F mutation
2:30 – 4:00 PM	Poster Session/Coffee Break	Salons E-G
Session IV: Clinical Microbiology and Infectious Diseases
Moderators:	Bob Hunter/Ruth Ann Luna
4:00 – 4:15 PM	Xiqi Li - University of Texas MD Anderson Cancer Center,Whole genome sequence based identification of an ST-5_sub-cluster of linezolid-resistant Staphylococcus epidermidis causing invasive disease in cancer patients
4:15 – 4:30 PM	Emily Welobob – University of Texas MD Anderson Cancer Center/Texas Childrens Hospital, Characterization of the healthy pediatric gut microbiome: reference ranges for microbial targets
4:30 – 4:45 PM	Robert Hunter – University of Texas Health Science Center at Houston, Tuberculosis is an obligate human parasite with multiple distinct stages in humans
4:45 – 5:00 PM	Ronald Carlton – Boca Biolistics Reference Laboratory, Dengue virus detection by trioplex RT-PCR and 3 serologic tests (NS-1, IgM, IgG)
Session Ends
5:30 – 7:00 PM	Opening Reception	Salons E-G Foyer
7:30 – 9:00 PM	Musicale Rehearsal	Conf. Room 4
8:00 PM	Young Young Fellows Section social event led by Josh Bornhorst. Meet in hotel lobby. All meeting attendees age 45 or younger (and spouses) are invited to attend.
Friday, May 18
7:15 AM	Departs for MD Anderson Cancer Center (5 min walk)
7:30 – 8:00 AM	Continental Breakfast	Onstead Auditorium
Session V: Molecular Pediatric Oncology
Moderator:	John Hicks
8:00 – 8:45 AM	Lola Lopez-Terrada – Texas Children’s Hospital/Baylor College of Medicine, Towards a biology-annotated pediatric liver tumors consensus classification
8:45 – 9:30 AM	Angshumoy Roy – Texas Children’s Hospital/Baylor College of Medicine, Clinical genomics of childhood solid tumors: lessons learnt from N-of-1 studies
9:30 - 10:00 AM	Break – Get Ready For Tour
10:00 – 11:00 AM	Tour of MD Anderson Cancer Center
11:00 – 11:10 AM	Walk back to Marriott Hotel
11:30 AM	Bus departs from hotel to NASA for special tour (Box lunches included)
12:15 PM	Arrive NASA
4:30 PM	Depart NASA
5:15 PM	Arrival at hotel
6:00 – 7:00 PM	Cocktail reception	Salons E-G Foyer
7:00 – 9:00 PM	Awards Banquet and Speaker (Requires Banquet Ticket) Thomas Caskey – Baylor College of Medicine, Precision medicine reduces genetics disease risk	Salons E-G
Saturday, May 19
7:00 – 8:00 AM	Continental Breakfast	Salons A-D Foyer
Session VI: Hematological Malignancies		Salons A-D
Moderators:	Keyur Patel/ Andy Nguyen
8:00 – 8:30 AM	Andy Nguyen – University of Texas Health Science Center at Houston, Deep learning application in pathology: Part I: predicting prognosis of Acute Myeloid Leukemia with cytogenetics, age, and mutations Part II: automated lymphoma diagnosis using digital images
8:30 – 8:50 AM	Keyur Patel – University of Texas MD Anderson Cancer Center, Opportunities and challenges in diagnosing inherited hematologic cancers
8:50 – 9:10 AM	Sean Post – University of Texas MD Anderson Cancer Center Unraveling the mechanism of a dual tumor suppressor and oncogene that drives hematologic malignancies
9:10 – 9:40 AM	Coffee Break	Salons A-D Foyer
9:40 – 10:20 AM	Claude P. Brown Memorial Lecture Stanley R. Hamilton – University of Texas MD Anderson Cancer Center, The road to precision oncology: are we there yet?	Salons A-D
Session VII: Solid Tumors		Salons A-D
Moderators:	Mary Coolbaugh-Murphy/Roland Valdes
10:20 – 10:40 AM	Jonathan Hoyne – Mayo Clinic, Systematic literature review as the key to the practice of evidence-based medicine
10:40 – 11:00 AM	Pei Zhao – University of Texas MD Anderson Cancer Center /Baylor College of Medicine, Clinical utility of NGS in the understanding of bioenergentics changes in tumorigenesis
11:00 – 11:20 AM	Stephanie Zalles – University of Texas MD Anderson Cancer Center, Monitoring of the disease progression in stage IV colorectal cancer patients through cfDNA based molecular testing
11:20 – 11:40 AM	John Hicks – Texas Childrens Hospital, Infantile spindle cell Rhabdomyosarcoma mimicking infantile fibrosarcoma: potential pitfall
11:40 – 12:00 PM	Devin Broadwater – Brooke Army Medical Center Clinical, morphologic and phenotypic features of histiocytic sarcomas, a multi-institutional review
12:00 – 1:30 PM	Lunch and ACS Business Meeting (Lunch Provided) All attendees are invited to attend the ACS business meeting, although only members can vote	Salons A-D
Scientific Session VIII & IX SPLIT Concurrent Sessions
Session VIII-A: Misc. Clinical Pathology Topics		Salons A-D
Moderators:	Nina Tatevian /Consolato Sergi
1:30 – 1:50 PM	Christina Koci – University of Texas MD Anderson Cancer Center, Detection of KIT pD816V mutations by droplet PCR
1:50 - 2:10 PM	Consolato Sergi – University of Alberta, Hirschsprung’s disease (Aganglionosis) approaching the miRNA-based genomic medicine of the 21st century
2:10 - 2:30 PM	Cheng Peng – University of Texas MD Anderson Cancer Center, Pan-Cancer analysis of copy number evaluation using high-throughput single-cell DNA
2:30 – 2:50 PM	Ashley Hayden – University of Texas MD Anderson Cancer Center, The Role of CYP2D6 single nucleotide polymorphism (SNP) for the prediction and treatment of chemotherapy-induced peripheral neuropathy (CIPN)
2:50 – 3:10 PM	Ruizhi Duan – University of Texas MD Anderson Cancer Center, Cytomolecular and clinical characteristics of HNRNPK gene duplication in hematological neoplasms
3:10 – 3:30 PM	Coffee Break	Salons A-D Foyer
Session VIII-B: Misc. Clinical Pathology Topics		Salons A-D
Moderators:	Eric Rosenbaum /Robert Brown
3:30 – 3:50 PM	Vanya Jaitly – The University of Texas Health Science Center McGovern Medical School, Morphoproteomics identifies crystal storing histiocytes as M2 polarized macrophages
3:50 - 4:10 PM	Jennifer O’Brien – University of Maryland School of Medicine, HLA antibody scree using a C1q binding assay for platelet transfusion support
4:10 - 4:30 PM	Roseen Salman – Baylor College of Medicine, Cell-based noninvasive prenatal testing enables highly sensitive genomic copy number analysis
4:30 – 4:50 PM	Wenxiao Jiang – Icahn School of Medicine at Mount Sinai Diagnostic value of PTEN in autism spectrum disorder and macrocephaly
Session IX-A: Anatomic Pathology, QA, and Diagnostic Errors		Salon E
Moderators:	Phil Foulis /Myra Wilkerson
1:30 – 1:50 PM	Joshua Bornhorst – Mayo Clinic, Lowering quality control operations cost through quality control material waste reduction
1:50 - 2:10 PM	George Chen – The Chinese University of Hong Kong Inhibition of IL-6 and p16 sensitizes hepatocellular carcinoma to sorafenib
2:10 - 2:30 PM	David Saulino – University of Texas Health Science Center at Houston, CRM1 expression in pancreatic adenocarcinoma correlates with surviving expression and the proliferative activity
2:30 – 2:50 PM	Bedia Barkoh – University of Texas MD Anderson Cancer Center, Simultaneous detection of PDGFRA and KIT mutations in GIST patients by NGS
2:50 – 3:10 PM	Kyle Kurek – University of Calgary, Systemic Kaposi Sarcoma in a pediatric renal transplant patient
3:10 – 3:30 PM	Coffee Break	Salons A-D Foyer
Session IX-B: Anatomic Pathology, QA, and Diagnostic Errors		Salon E
Moderators:	Kyle Kurek/Roger Bertholf
3:30 – 3:45 PM	Philip Foulis – James A. Haley Veterans’ Hospital Urine cytology: standardization of processes with decreased diagnostic interpretative error
3:45 - 4:00 PM	Wenrui Ye – University of Texas MD Anderson Cancer Center, Mutational profiling of centrifuged supernatant fluid from fine-needle aspiration of thyroid nodules
4:00 - 4:15 PM	Mehrdad Rajaei – Baylor College of Medicine, Targeted mutagenesis induced by CRISPR-Cas9 in mouse tyrosinase gene
4:15 – 4:30 PM	Meenakshi Bidwai Bhattacharjee – University of Texas Health Science Center at Houston, Rare/unusual pathologies in epilepsy surgical resections, and their implications for genetic disease identification in some cases
4:30 – 4:45 PM	Penn Muluhngwi – University of Louisville, Circulating antibodies to R132H isocitrate dehydrogenase as a “Liquid Biopsy” biomarker of gliomas
4:45 – 5:00 PM	John Hicks – Texas Childrens Hospital Pediatric Nodular Fasciitis involving head and neck region with MYH9-USP6 rearrangement
Session Ends
5:00 – 7:00 PM	Dinner on your own
7:00 – 9:00 PM	Musicale (wine, beer, hors d’oeuvres at intermission) Note: Musicale open to all attendees (no ticket required to attend)	Salon F
Posters (Thursday Set up 7:30-8 am and take down by 5:30 pm) Salons E-G
P1	Brette Hannigan et al. – University of Texas MD Anderson Cancer Center, Mutational profiling of the centrifuged supernatant fluid from fine needle aspiration of lung carcinomas
P2	Helen Mata et al. – University of Texas MD Anderson Cancer Center/Texas Childrens Hospital, Genomic profile based prognostic markers for Wilms tumor
P3	Robert Brown et al. – University of Texas Health Science Center/St Petersburg State Pediatric Medical University, Morphoproteomics identifies the foamy alveolar macrophage as an M2 phenotype with PD-L1 expression in Mycobacterium tuberculosis: implications for host immune surveillance
P4	Shima Mousavi et al. – Baylor College of Medicine, Improving accuracy of serrated colon polyp designation
P5	Marjorie David et al. – Baylor College of Medicine/Texas Childrens Hospital, Atypical small cell carcinoma of the ovary, hypercalcemic-type diagnosed by multimodal molecular analysis
P6	Carissa Wachtler et al. – Access DX laboratory evaluation of DNA extraction methods using throughput automation for pharmacogenetics testing
P7	Madison Doty et al. – MD Anderson Cancer Center, Myeloid neoplasms with t(3;8)(q26;q24) chromosomal rearrangement
P8	Jayson Pagaduan et al. – Baylor College of Medicine/Texas Childrens Hospital, Validation of the Procalcitonin assay on Abbott architect i1000
P9	Annie Koenig et al. – University of Texas MD Anderson Cancer Center, Evaluation of bacterial genotyping methods for characterization of a hospital outbreak caused by invasive Streptococcus dysgalactiae subsp. Equismilis
P10	David Saulino et al. – University of Texas Health Science Center at Houston McGovern Medical School, Effect of patient gender and ethnicity on eosinophil count in colorectal biopsies
P11	Manju Ambelil et al. – University of Texas Health Science Center at Houston McGovern Medical School, Frequency and clinical significance of equivocal CMV immunohistochemical staining in colorectal biopsies
P12	Suhair Al Salihi et al. – University of Texas Health Science Center at Houston McGovern Medical School, Pancreatic acinar metaplasia in distal esophageal biopsies is associated with PPI and NSAID use
P13	Lee Springer et al. – The Bellevue Hospital, Utility and performance of point-of-care rapid drug screen
P14	Parnian Ahmadi Moghaddam et al. – University of Texas Health Science Center at Houston McGovern Medical School, M2 polarized macrophages in HIV+ patients express cyclooxygenase (COX)-2: pathogenesis and therapeutic implications
P15	Charlotte Myers et al. – Houston Methodist Hospital/ University of Texas Health Science Center at Houston McGovern Medical School, Unique constellation of placental findings associated with protein S deficiency
P16	Mahesheema Ali et al. – Baylor College of Medicine/ Texas Childrens Hospital, Vitamin D laboratory test utilization in a pediatric hospital
P17	Alex Tatevian – Foundation for Research in Acupuncture & Integrative Medicine (FRAIM), Instrumental modalities for utilization of “biologically active points”
P18	Jessica Tomsula et al. – Houston Methodist Hospital/ University of Texas Health Science Center at Houston McGovern Medical School, Placental involvement by acute promyelocytic leukemia during initial presentation of the disease
P19	Daphne Massey et al. – University of Texas Health Science Center at Houston McGovern Medical School, Fulminant hepatic failure in a child: is influenza A (H1N1) virus hepatotropic?
P20	Jincy Veliyathu et al. – University of Texas MD Anderson Cancer Center, Detection of EGFR sensitizing mutations in circulating cell-free DNA by ddPCR
P21	Elizabeth Staley et al. – University of Alabama at Birmingham/ The University of Oklahoma Health Science Center, Paraneoplastic-antibody testing, patterns, positivity, and follow-up. A one year single center experience
P22	Joseph Drwiega et al. – University of Alabama at Birmingham, Formalin versus Bouin solution for testicular biopsies: which is the better fixative?
P23	Alexander Feldman et al. – University of Alabama at Birmingham, Primary diffuse leptomeningeal gliomatosis: a mimicker of tuberculous meningitis
P24	Stephanie Zalles et al. – University of Texas MD Anderson Cancer Center, Clinical validation of droplet digital PCR to detect mutations in codons 12, 13, 61, in KRAS and NRAS
P25	Liyun Cao et al. – University of Alabama at Birmingham, Comparison of measured and calculated low-density lipoprotein cholesterol at different triglyceride levels
P26	Robert Brown et al. – University of Texas Health Science Center at Houston McGovern Medical School, EZH2, Sirt1, c-Myc, CXCR4 pathways may block differentiation in sinonasal undifferentiated carcinoma

Corporate Sponsors for the Annual Meeting

The Association of Clinical Scientists gratefully appreciates the financial support it receives from sponsors of each annual meeting. This support helps defray the expenses associated with ancillary activities during the annual meeting such as the Opening Reception, the Annual Awards Banquet and Reception, the Musicale and Art Show, continental breakfasts for attendees, coffee breaks, and other expenses. None of the contributed funds is used for actual educational activities or speaker expenses, as this would be a violation of ACCME policies.

Our contributors are categorized on the basis of their contributions into the following categories:

Platinum	> $5000
Gold	$2000 - $4999
Silver	$1000 - $1999
Bronze	$500 - $999

 

Platinum Sponsors

 

Gold Sponsors

 

Silver Sponsors

 

Bronze Sponsors

 

DUE DATE EXTENDED TO FEBRUARY 16

Abstract Instructions

Abstract Submission for the 2018 Annual Meeting is now available by clicking on the link below. Please note that all authors listed on each abstract must complete and sign the Disclosure of Relevant Financial Relationships form which is part of the Abstract Instructions. The deadline for submission of abstracts is Friday, February 16, 2018.

Important note: authors must specify on page 2 of the form whether the abstract is being submitted for oral presentation only, poster presentation only, or either oral or poster at the discretion of the Program Committee.

If you are age 45 or younger, regardless of whether you are a member of the Association, you are eligible to be considered for the annual Young Clinical Scientist Award, which is based upon presentations at the Annual Meeting. In addition to being age 45 or younger, if you are either a trainee (fellow, resident, etc.) or an early career professional, you are also eligible to be considered for one of four travel grants (see detailed description below). Please check the box on the abstract submission form to indicate that you are age 45 or younger and wish to be considered for either the Young Clinical Scientist Award or one of the travel grants.

2018 ABSTRACT SUBMISSION INSTRUCTIONS

ANNOUNCEMENT OF 2018 ASSOCIATION TRAVEL GRANT AWARDS

The Association of Clinical Scientists will award a total of four $500 travel grants (two each in the two categories described below) to individuals age 45 or younger based on the quality of their submitted abstract. The Association’s Awards Committee reviews all of the abstracts and determines the recipients of these four awards.

Young Investigators

This program is designed to encourage young investigators to consider a career in academic laboratory medicine. The travel award’s purpose is to offset some of the costs associated with attending our annual meeting. Residents, fellows, and students in a doctoral program in health sciences, participating in research with a member of ACS, or sponsored by an ACS member are eligible. Students in programs leading to non-doctoral degrees conducting research with an ACS member may be considered upon written request from the ACS sponsor to the chair of the Young Investigator Awards Program. The award winner will be recognized at the meeting, give a podium presentation, and receive a $500 award to be used to defray the cost for the subsequent Association meeting with waived registration fee.

Early Career Professional in Pathology or Clinical Sciences

This program is designed to encourage professionals early in their career to attend our annual meeting, share their research, and network with the membership. Clinical scientists or pathologists within the first five years of practice, subsequent to their training, are eligible for this award. The award winner will be recognized at the meeting, give a podium presentation, and receive a $500 award to be used to defray the cost for the subsequent Association meeting with waived registration fee.

Education Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Association for Clinical Chemistry (AACC) and the Association of Clinical Scientists. The AACC is accredited by the ACCME to provide continuing medical education for physicians.

Meeting Objectives

Target audience:

Physicians, Pathologists, Laboratory Directors/Managers/Supervisors, Clinical Laboratory Scientists/Medical Technologists, Residents/Fellows/Trainees, Students (Graduate and Undergraduate)

Learning objectives:

After participating in this program, you should be able to:

Registration

Register for 138^th Annual Meeting

in Houston, TX, May 16-19, 2018.

The Association’s Shopping Cart is fast and convenient. It uses a secure PayPal system to accept payments. To be sure that the Association’s office receives the information that is required to properly register you for all selected items, please follow these steps:

Note: speakers receive complimentary registration for the day of their lecture, excluding luncheons and CME credits. Speakers not desiring to attend the luncheon seminar, banquet, or to receive CME should skip Step 1 and proceed to Step 2 to add Complimentary Items.

1. Select all desired items in the shopping cart.
2. Select any complimentary items.
3. Complete the registrant information. If you are an administrative assistant making the registration for a member, please enter your name. This is important.
4. Press the button “Send Email Notification.” This ensures that the Association’s office receives the required information. Please note that this step does not send any credit card information to our office.
5. Press the yellow “Check Out with PayPal” button.

1. Make Shopping Cart Selections

Regular Full Meeting Registration For all Fellows of the Association and non-members attending the full meeting; includes one banquet ticket and continuing education credits, if desired

$475

Meeting Registration, Emeritus, Assoc. Fellows & Trainees For all Emeritus or Associate Fellows of the Association, all trainees, residents, fellows, MTs, and students attending the full full meeting; includes banquet ticket and CE credits, if desired

$200

Single Day Registration Thursday Only; includes luncheon and continuing education credits if desired

$200

Single Day Registration Saturday Only; includes luncheon and continuing education credits if desired

$200

Friday Afternoon NASA Tour, May 18, (see program) NOTE - this tour includes two special “back stage” events not open to general public. You will be required to provide a copy of your Driver’s License or Passport to the ACS office no later than two weeks prior to the conference. Price includes bus and box lunch. Note – the US government and NASA will not allow citizens of certain specified countries to attend this special tour. Meeting registrants from those countries can still visit the full “public” parts of the NASA facility, but not the two “back stage” events. See the linked document for a list of the excluded countries.

$50

Extra Banquet Tickets, Friday, May 18

$95

Include Renewal of Dues (Fellows)

$225

Include Renewal of Dues (Assoc. Fellows)

$50

2. Add Complimentary Items

Meeting Registration, Complimentary $0.00 For all speakers only attending the meeting for the day of their lecture; excludes CE and banquet ticket

Count:

Luncheon Seminar, Thursday, May 17 Complimentary for all attendees with Full Meeting Registration (please indicate attendance for headcount estimation)

Count:

Musicale, with Wine & Cheese Intermission $0.00 Complimentary for all attendees, please indicate attendance for headcount estimation

Count:

3. View Shopping Cart and Edit if Needed

4. Complete Registrant Information and Send Notification Email to ACS Office

Future Meetings

2019

Hershey, PA, (tentative) Drs. Keri Donaldson and Myra Wilkerson, Program Co-Chairs

2020

Banff, Alberta, Canada. (tentative) Dr. Kyle Kurek, Program Chair

Accommodations

The hotel for the Association’s 138th Meeting is the Houston Marriott Medical Center, 6580 Fannin Street, (Driveway Entrance on 1730 Dryden Road), Houston, TX, 77030. Enjoy thoughtful services and upscale amenities at Marriott Houston Medical Center. Situated on the MetroRail and across the street from the largest medical center in the world, our hotel provides incredible convenience to top health care institutions including MD Anderson Cancer Center, Texas Children's Hospital and Houston Methodist Hospital. After visiting the Med Center or attending a conference, appease your hunger with regionally-inspired cuisine paired with premium libations at our on-site restaurant, Driscoll's. Retreat back to ultimate relaxation in our newly remodeled guest rooms or concierge lounge. During free time, discover attractions such as the Museum of Natural Science, Houston Zoo, Hermann Park and Rice University, all less than two miles away. Whether you're planning an elegant wedding, educational session, or business meeting, we boast five stylish event rooms with nearly 9,000 sq. ft. of combined space. Travel brilliantly by making a reservation at Marriott Houston Medical Center today!

The Association’s contracted room rates for the 138th Meeting are $139.00 Standard Guest Room with 17% applicable state and local taxes. The hotel’s phone number is (713) 796-0080 and the Association's discount rates can be found at Marriott's website here. Be sure to mention the Association of Clinical Scientists meeting when making reservations to get the discounted rates.

Additional Information
Standard Parking Rates (subject to change):

Valet Parking
Valet parking, fee: 28 USD daily

Self Parking
Available in the Scurlock Towers Garage; Entrance on 6535 Main St.
$13 USD daily, no in/out privileges.

Transportation

Houston is served by two major airports.

William P. Hobby Airport – HOU

Hotel direction: 13.4 miles NW and the hotel does not provide a shuttle service.

• Estimated taxi fare: $40 US (one way).
• Alternate transportation: SuperShuttle Service (www.supershuttle.com); fee: $25 US (one way), reservation required.

George Bush Intercontinental Airport – IAH

Airport Phone: +1-281-230-3000
Hotel direction: 24 miles SW and the hotel does not provide a shuttle service.

• Estimated taxi fare: $65 US (one way).
• Alternate transportation: SuperShuttle Service (www.supershuttle.com); fee: $25 US (one way), reservation required.

Archive of Past Meetings

Highlights of 131st Meeting, Louisville, Kentucky May 18-22, 2011

---

In Memory of F. William Sunderman, Jr., MD, (June 23, 1931 – April 1, 2011)

The 131st meeting of the Association of Clinical Scientists was held in memory of Bill Sunderman, Jr., who served the Association for 42 years as Secretary-Treasurer, as Editor-in-Chief of the Annals of Clinical and Laboratory Science, and in numerous other capacities.

F. William Sunderman Jr. (Bill), who died on April 1, 2011 at the age of seventy-nine was, like his illustrious father of the same name, a physician and scientist, both of whom made many significant contributions to the field of laboratory medicine and especially the sub-specialty of nickel toxicology. Both father and son were devoted servants of the Association of Clinical Scientists as founders, scientific meeting organizers and editors of the Annals of Clinical and Laboratory Science. Bill was born in Philadelphia, Pennsylvania on June 23, 1931. He graduated as valedictorian from Central High School in Philadelphia in 1948 and with a BS degree from Emory University in Atlanta in 1952. He underwent his medical training at Thomas Jefferson University in Philadelphia where he obtained the M.D degree in 1955. From 1955 to 1956 he was an intern at Thomas Jefferson University and from 1956-58 a fellow in metabolic research at the same location. It was at this time that Bill considered specializing in nephrology but the depressing nature of this field before hemodialysis treatment was developed discouraged him and he entered the same field as his father namely clinical pathology. His first foray was as the Chief of the Clinical Chemistry Service at the US Naval Medical School in Bethesda Maryland from 1958-60. At this time He was a lieutenant in the US Navy. It is evident that Bill’s primary interest was in clinical chemistry since his first publications beginning with “The clinical significance of measurements of protein-bound iodine (1954)” could all be classified as belonging to this discipline. Following a spell (1961-64) as Instuctor in Medicine, Thomas Jefferson University, Philadelphia, Bill took on even more onerous service and academic responsibility by moving to the Department of Pathology at the University of Florida in Gainesville, Florida where he was Director of Clinical Laboratories and Associate Professor of Pathology. The Shands Teaching Hospital at the University of Florida opened just six years before Bill’s arrival but already had an excellent tradition in clinical pathology since the first director of laboratories was Dr. John Bernard Henry, a distinguished pathologist who went on to make many significant contributions. Bill fitted well into the clinical laboratory and put together an excellent staff of faculty and technical experts. One change that he did make, however, was brought about when the processing of a seventy-two hour fecal fat specimen which required homogenization on a paint can shaker. The container’s lid came loose during the shaking process resulting in an environmental disaster throughout the clinical laboratory. Thereafter, Bill decreed that the processing should take place in a more remote and contained place. Bill exhibited considerable administrative skills in directing and developing the clinical laboratory services. He initiated the development of one of the first clinical laboratory computer systems complete with cumulative reporting and, for the first time, the application of delta checking of results. He also was interested in developing more sophisticated analytical techniques, something that was part of his legacy for the next four decades. However, it was the creation of a research program in concert with his service and teaching skills that shaped the start of his academic career in a leadership position. Bill was well funded by the American Cancer Society and his laboratory focused on nickel carcinogenesis. He was remarkably creative: he had, as aptly stated by his department chairman Dr. Joshua Edwards, “the ability to shed ideas like water off a duck’s back”. A steady stream of papers came out of his laboratory creating new avenues of research. Bill was also a gifted teacher and his lectures, especially those presented to the medical students were well-organized, well-prepared and well-received by his audience. Throughout his life Bill had little interest in sports but he did attend the University of Florida football games, probably because he lived just across the street from Florida Field, the home of the Fighting Gators. Bill’s wife, Carolyn, came to the University of Florida as a resident in pediatrics and they resided in a lovely comfortable home near the university and it was here that their first child was born. It was also at the University of Florida that Bill was starting to attract students to his laboratory, many from outside the United States. This continued in his later career and many distinguished medical scientists from countries around the world, including Poland, Yugoslavia, Japan and many others spent time in Bill’s laboratory and took their knowledge acquired there to establish their own research programs.

In 1968, after achieving the academic rank of full professor and having established himself as an internationally recognized leader in laboratory medicine, Bill decided to move on to the next step: that of department Chair. He received several offers, some from well-established programs, but eventually decided on a newly established medical school in Farmington, Connecticut as part of the University of Connecticut. His position would be as chairman of the department of laboratory medicine, one of the few departments at that time to be separate from the department of pathology. He also was given a joint appointment as professor of pharmacology. Bill’s rationale reasoned that in becoming head of a new department in a new medical school he could form and shape it according to his own vision; what developed would depend largely on his leadership. He went to Farmington inheriting no “baggage”. He also felt that a smaller hospital, as the Shands Teaching Hospital in Florida was during his tenure there, minimized his time spent on administrative duties providing more time for research and other academic activities. At the time of his arrival exchanging the colder climes of New England from the warmth of Florida, the new hospital and medical school in Farmington was just a large hole in the ground. His clinical and research laboratories were situated at the McCook Hospital in Hartford. Eventually the new facility was complete and Bill spent the next twenty-nine years directing a vibrant and productive program. He was now in his prime. His research developed along new lines of investigation, as is the case with all research programs, but the main focus was on the chemical toxicology and clinical chemistry of metals with nickel, of course, being the primary metal of interest. Bill maintained a high and consistent level of funding from The National Institutes of Health, The American Cancer Society, The United States Department of Energy, The Environmental Protection Agency and others throughout his career during which he published two hundred and fifty-eight articles in refereed journals, eighty-seven articles in monographs, manuals and texts, and eighteen books. As he told his junior faculty and students, “Publications are the best form of insurance for the academician”.

Almost all energetic, ambitious and successful scientists eventually become involved in national and international scientific organizations. For many years (1972-1988), Bill focused his considerable degree of energy on the International Union of Pure and Applied Chemistry (IUPAC), Clinical Chemistry Division. His efforts were mainly directed towards the Commission on Toxicology and its various subcommittees particularly the Nickel Subcommittee. The international nature of IUPAC provided Bill with the opportunity to travel and to apply his scientific and organizational skills worldwide. The Commission on Toxicology held their first international meeting in Monte Carlo in 1977 with, and under Bill’s leadership, it enjoyed considerable success. Many other meetings followed including several of the Nickel Subcommittee which was well supported by the nickel-producing industry. The well-known problem of nickel carcinogenesis in nickel-producing workers was of concern to the industry and Bill’s efforts added greatly to the understanding and prevention of this devastating problem in these workers. It was at the last IUPAC meeting that Bill helped to organize that his skills and knowledge were so evident. With his usual talent he planned the scientific program putting together a cohesive schedule that would not be instinctive to most people but which was second nature to Bill. The conference was in Vancouver, Canada and when the time came for him to present his own paper he was asked a question during the discussion period as to the pH of some reagent. He immediately gave the correct answer to two decimal places demonstrating his comprehensive knowledge of the experiments that had been carried out in his laboratory. Bill’s involvement in IUPAC inspired many young scientists and allowed him to interact with people who were working in fields different from his own. He was also involved in other international organizations including the International Federation of Clinical Chemistry, International Commission on Occupational Health and others, but none occupied his energies as much as IUPAC. This International involvement allowed Bill to interact with scientists around the world, creating an aura of good fellowship that he cherished.

Bill gave a lifetime of service to the Association of Clinical Scientists which had been founded by his father. He served as president 1964-65 and in 1969 upon the death of Dr. Bob McFate, he took over as secretary-treasurer; Bill held this position until his own death. On top of these burdensome duties, in 1999 he added those of editor-in-chief of the Annals of Clinical and Laboratory Science again holding this position until his death. He took over from his father, the first editor who decided to “take a breather” at the age of 101. Bill played a major role in the planning and organization of the Association meetings and always did an on-site visit in order to work with the local committee. He always put together the finishing touches making sure that the meeting rooms were wide and spacious rather than long and narrow, and that the meals and refreshments were appealing but not extravagant. The scientific program was his specialty and, as stated earlier, he had a knack of putting together cohesive sessions and would bracket a speaker “of limited ability” with a couple of excellent presentations. (He learned this trick from his Father of course.) Bill was always kind to speakers especially to young clinical scientists embarking on their careers. He would remark “Wonderful paper and great presentation – your best ever” to inspire confidence in those unsure of their abilities.

Bill always was a key performer in the Musicale, since the early 1970s a feature of the Association meetings. Many of us have fond memories of Bill, his father and a few other highly talented musicians who were Association Members, entertaining us with accomplished performances of chamber music. Bill was a gifted violist having decided early in life not to follow his Father in everything. Bill Senior was a violinist who had the distinction of owning several wonderful instruments including a Stradivarius known as the Irish Strad. Bill Junior eventually inherited this violin, which he sold and used the proceeds to buy a really excellent viola, something he enjoyed immensely. The Arts, especially chamber music, were most important to Bill, and provided a means of bonding with his professional and social friends and family. He will be intensely missed by a remarkable diversity of friends. Many of these friends bonded with Bill and his family through weekly evenings of chamber music. These sessions were typically followed by convivial and uplifting conversation.

Bill achieved many awards throughout his career, the major ones being as follows: The Ames Award for Outstanding Contributions to Clinical Chemistry from the American Association for Clinical Chemistry (1978); Clinical Scientist of the Year (1976), Recipient of Gold Headed Cane (1998) and Diploma of Honor for Outstanding Contributions to Clinical Science (2007) from the Association of Clinical Scientists; Achievement Award for Research on Nickel Toxicology (1992) and Chemistry and Human Health Division Award for Leadership Clinical Chemistry and Toxicology (2010) from IUPAC.

Bill retired from the Chair of Laboratory Medicine at the University of Connecticut in 1997 and he and his wife Carolyn moved to Whiting, Vermont. In his retirement he was a research professor of pathology at the University of Vermont, and a visiting scholar in chemistry and biochemistry at Middlebury College while continuing his extensive duties for the Association of Clinical Scientists.

From the 1970s onwards, Bill and Carolyn always had owned a series of Labrador Retrievers each of which he adored. The first one was acquired at an Association meeting in Washington and came from a noted breeder in Middleburg, Virginia; the contact being made by this writer.

Bill's beloved wife, Carolyn predeceased him in 2002. His brother, Joel Baily Sunderman, and sister, Louise Lehr Sunderman also predeceased him. He is survived by his daughter and son-in-law, Emily L. Sunderman and Michael J. Lee, of Cornwall; daughter and son-in-law, Elizabeth R. Sunderman and Robert C. Hauck of Salt Lake City, Utah; son and daughter-in-law, Frederick W. Sunderman III and Kathleen L. Sunderman of Freeland, Michigan; mother-inlaw, Frances L. Reynolds of Chestertown, Maryland; grandson, Carter S. Lee of Cornwall; granddaughters, Hailey L. and Caitlin E. Hauck of Salt Lake City; grandson, F. William Sunderman IV, and granddaughter, Chloe E. Sunderman of Freeland, Michigan.

Dr. F. William Sunderman Jr. was much loved by his family, friends, colleagues and many in the scientific community. He was kind, helpful and full of encouragement and had a broad range of interests and talents. We can hope but not expect to see his like again.

John Savory,
Charlottesville, Virginia

---

Claude P. Brown Memorial Lecture

James L. Wittliff, Ph. D., M.D. hc, FACB: Deciphering the genomics and proteomics of human cancer to predict clinical behavior.

Professor Wittliff’s team is internationally regarded for studies of estrogens and their mimics with receptor proteins in human cancer, exploiting proteomics and genomics. His laboratory was among the first to report estrogen receptors in a breast cancer biopsy predicted a patient’s response to hormone therapy. This finding led to collaborations with the NSABP, establishing Tamoxifen as adjuvant therapy for breast cancer and use of receptors as biomarkers of patient prognosis and response. With NEN/DuPont, Dr. Wittliff developed the original FDA-approved kits for assessing estrogen and progestin receptors in biopsies, celebrated as a major contribution to laboratory medicine. His laboratory, designated the National Reference Facility for historical clinical trials in North America, served more than 400 laboratories worldwide. Focusing expertise on molecules exhibiting estrogen mimicry, Dr. Wittliff and IA, Inc. patented receptor-based biosensors detecting endocrine-disrupting compounds in the environment. Awards include Outstanding Contributions to Clinical Chemistry from the AACC, Goldsmith Research Excellence Award from the American Cancer Society and the University of Louisville President's Award for Career Achievements. More than 200 students and research fellows from 45 countries have trained in his laboratory. Currently Dr. Wittliff directs the Institute for Molecular Diversity & Drug Design, which he co-founded.

---

Clinical Scientist of the Year Award

Presented to Roland Valdes, Jr., PhD by Magali Fontaine, MD, PhD

Dr. Valdes is Professor and Senior Vice-Chairman in the Department of Pathology and Laboratory Medicine, University of Louisville School of Medicine. He is also Professor of Biochemistry and Molecular Biology, serves as Chief of Clinical Chemistry and Toxicology and is the founder and director of a Postdoctoral Fellowship Program in Clinical Chemistry in the Department of Pathology and Laboratory Medicine. Dr. Valdes is nationally and internationally recognized as a leader in advancing the profession of clinical chemistry through his major contributions in promoting clinical chemistry as a discipline via the scholarships of clinical service, research, and teaching. As a result of these activities, Dr. Valdes has played a major role in heading and participating in numerous national committees and in leading several of our key professional organizations. He has served as president of the Clinical Ligand Assay Society (CLAS), president of the National Academy of Clinical Biochemistry (NACB), and is a past-president of the Commission for Accreditation in Clinical Chemistry (ComACC). Dr. Valdes has also served on the Board of Directors of the American Association for Clinical Chemistry (AACC) and as a director on the American Board of Clinical Chemistry (ABCC). Additionally, Dr. Valdes has been engaged in many other national work groups including federal government advisory committees. His scientific interests involve discovery and characterization of the mammalian cardenolides and their pathophysiologic role in cardiovascular disease and, more recently, in cancer therapeutics. For this scientific work, he has been awarded numerous grants from the NIH and other public and private organizations as well as several distinguished scientist awards from professional organizations such as the NACB, the CLAS, and the ACS. Dr. Valdes has authored more than 250 publications. In addition to his other research laboratories, Dr. Valdes is the principle founder and President of the Pharmacogenetics Diagnostic Laboratory at the University of Louisville where he is currently working on transitioning the science of pharmacogenetics and proteomics into clinical laboratory practice.

---

Diploma of Honor

Presented to Charles D. Hawker, PhD, MBA by Robert L. Hunter, Jr., MD, PhD

Dr. Charles Hawker is Scientific Director for Automation and Special Projects at ARUP, where he has been for 19 years. Dr. Hawker is also Professor (Adjunct) of Pathology in the University of Utah, School of Medicine. Previously, over a twenty year period, he held various positions in research and development and management at Laboratory Procedures, Inc. (Upjohn) and SmithKline Beecham Clinical Labs. At ARUP he has installed several major automation and robotic systems that have made ARUP one of the country’s most automated laboratories. He is a past president of the Association of Clinical Scientists, the National Academy of Clinical Biochemistry (NACB), and the Clinical Ligand Assay Society (CLAS). He has received the John V. Bergen Award of the Clinical and Laboratory Standards Institute (CLSI), the Professor Alvin Dubin Award from the NACB, and the Becton Dickinson Award from the Association for Laboratory Automation.

He has chaired automation committees in both CLSI and Health Level 7 and recently chaired the CLSI Subcommittee on Specimen Labels: Content and Location, Fonts, and Label Orientation. He is a co-author or author of four book chapters on clinical laboratory automation and a frequent lecturer on laboratory automation to national and international audiences. He has three issued patents and has published 40 peer-reviewed papers, 13 book chapters or invited reviews, and 42 abstracts. His most recent research efforts have focused on the use of machine vision systems for automated quality inspection of clinical laboratory specimens, particularly the development of an automated camera system that uses optical character verification (OCV) to identify mislabeled specimens.

---

Young Clinical Scientist of the Year Award

Presented to Peter C. Hu, PhD by Armand B. Glassman, MD

Dr. Peter Hu is an Associate Professor in the School of Health Professions (SHP) and is Director for the Molecular Genetic Technology Program. He received his Bachelor’s degree from Purdue University in 1990 with a major in Psychology and a minor in Chemistry. He later received his Master’s degree from Lamar University majoring in Microbiology and subsequently a Doctor of Philosophy from Trident University International (TUI) Healthcare Administration and Molecular Genetics. Dr. Hu also holds 3 specialty clinical certifications in Molecular Biology, Cytogenetics, and Clinical Laboratory Science. He joined MD Anderson Cancer Center (MDACC) in1995 and has worked in both clinical and academic environments.

Dr. Hu was a founding faculty member in the SHP and played an important role in MDACC achieving degree granting status by the Texas Coordinating Board in 2002, the Southern Association for Colleges and Schools (SACS) accreditation in 2005, the addition of the junior year curriculum approval in 2008, and SACS reaffirmation in 2010. He was also instrumental in the approval of the Molecular Genetic Technology program by the Texas Coordinating Board in 2005 and the program’s professional accreditation by the National Accrediting Agency for Clinical Laboratory Sciences (NAACLS) in 2005 and its reaffirmation in 2010.

Dr. Hu has taught over 28 courses within the SHP and has served or is currently serving as Chair or as member on 38 institutional committees. Dr. Hu has published over 100 abstracts, 17 papers, and 1 book chapter. He is on the editorial board for 3 journals and a column editor for another. He has received 41 recognitions and awards including the recent Young Clinical Scientist award from the Association of Clinical Scientists for his presentation on using saliva cells to detect microsatellite instability in hereditary non-polyposis colon cancer patients and their at-risk family members . Professionally, he has served as the President for Texas Association for Clinical Laboratory Science, Education Director and Chair of the Genetics Educators Committee for the Association for Genetic Technologist, Chair of the Molecular Scientific Assembly, Continuing Education Approval Committee, and Awards Subcommittee Chair for the American Society for Clinical Laboratory Science, a member of the Review Committee for Accredited Programs under NAACLS, and has served as a clinical laboratory science programs inspector for 10 year. Dr. Hu regularly presents at state, national, and international levels on topics dealing with genetics research, clinical laboratory sciences, and education.

Chronology of Previous Association Meetings

1. Sept 8, 1954; Shoreham Hotel, Washington, DC; US Naval Medical Center, Bethesda, MD (Workshop on Clinical Hemoglobinometry)

2. Nov 19-20, 1954; Bellevue-Stratford Hotel; Jefferson Medical College; Philadelphia, PA

3. April 1-2, 1955; Kenmore Hotel; Harvard Medical School; New England Deaconess Hospital; Boston, MA

4. Oct 7-8, 1955; Shoreham Hotel, Washington, DC: US Naval Medical Center, Bethesda, MD (Workshop on Blood Glucose)

5. Dec 9-10, 1955; Drake Hotel; University of Chicago, Argonne Cancer Research Hospital; Chicago, IL

6. April 6-7, 1956; Raleigh Hotel; Arlington Hospital; Washington, DC (Adoption of Constitution)

7. Oct 5-6, 1956; Shoreham Hotel, Washington, DC; US Naval Medical Center, Bethesda, MD (Workshop on Serum Proteins)

8. Dec 7-8, 1956; Bellevue-Stratford Hotel; Thomas Jefferson Medical College; Philadelphia, PA

9. March 1-2, 1957; Sheraton Hotel; Northwestern University Medical School; Chicago, IL

10. July 15, 1957; Royal Army Medical College, London, UK (International Workshop on Hemoglobinometry)

11. Sept 27-28, 1957; Shoreham Hotel, Washington, DC; US Naval Medical Center, Bethesda, MD (Workshop on Serum Cations)

12. Dec 13-15, 1957; Bellevue-Stratford Hotel; Thomas Jefferson Medical College; Philadelphia, PA

13. May 9-11, 1958; Sheraton-Lincoln Hotel; Indianapolis General Hospital; Eli Lilly Co; Indianapolis, IN

14. Oct 10-12, 1958; Park-Sheraton Hotel; New York, NY

15. Feb 26-Mar 1, 1959; Holiday Inn; Mobile Infirmary; Mobile, AL

16. Oct 9-11, 1959; Sheraton-Park Hotel; Washington Hospital Center; Washington, DC

17. March 3-5, 1960; DeWitt Clinton Hotel; Wadsworth Laboratory of NY State Health Department; Albany, NY

18. Nov 4-6, 1960; Shoreham Hotel; Washington Hospital Center; Washington, DC (Exocrine and Endocrine Functions of the Pancreas)

19. April 14-16, 1961; Bellevue-Stratford Hotel; Thomas Jefferson Medical College; Philadelphia, PA

20. Oct 27-29, 1961; Shoreham Hotel; Washington Hospital Center; Washington, DC (Thyroid and Parathyroid Functions)

21. April 6-8, 1962; Sheraton Hotel; Northwestern University Medical School; Chicago, IL

22. Oct 25-28, 1962; Statler-Hilton Hotel; Washington Hospital Center; Washington, DC (Hemoglobin, its Precursors and Metabolites)

23. April 25-28, 1963; Sheraton Hotel; Louisville Medico-Chirugical Society; Louisville, KY

24. Oct 24-27, 1963; Statler-Hilton Hotel; Washington Hospital Center; Washington, DC (Serum Proteins and the Dysproteinemias)

25. May 1-3, 1964; Bellevue-Stratford Hotel; Jefferson Medical College; Philadelphia, PA

26. Nov 13-15, 1964; Statler-Hilton Hotel; Washington Hospital Center; Washington, DC (Clinical Pathology of the Serum Electrolytes)

27. April 29-May 2, 1965; Statler-Hilton Hotel; St. Albans Naval Hospital; New York, NY

28. Nov 11-14, 1965; Statler-Hilton Hotel; Washington Hospital Center; Washington, DC (Clinical Pathology of Infancy)

29. April 29-May 1, 1966; Palmer House; Chicago Board of Health Laboratories; Chicago, IL

30. Oct 20-23, 1966; International Inn; Washington Hospital Center; Washington, DC (Laboratory Diagnosis of Liver Diseases)

31. May 4-7, 1967; Robert Meyer Hotel, Orlando, FL; Kennedy Space Center, Cape Canaveral, FL; University of Florida College of Medicine, Gainesville, FL

32. Nov 2-5, 1967; Shoreham Hotel; Washington Hospital Center; Washington, DC (Laboratory Diagnosis of Kidney Diseases)

33. May 16-19, 1968; Peck Inn; University of Arkansas Medical School; Little Rock, AR

34. Nov 7-10, 1968; Shoreham Hotel; Washington Hospital Center; Washington, DC (Laboratory Diagnosis of Diseases Caused by Toxic Agents)

35. April 24-27, 1969; Malaga Inn; Mobile Infirmary; Mobile, AL

36. Nov 6-9, 1969; Mayflower Hotel; Washington Hospital Center; Washington, DC (Laboratory Diagnosis of Endocrine Disorders)

37. April 23-26, 1970; Ponchartrain Hotel; Wayne State University Medical School; Detroit, MI

38. Nov 6-8, 1970; Shoreham Hotel; Washington Hospital Center; Washington, DC (Chemical Hematology)

39. April 22-25, 1971; Hotel Sonesta; University of Connecticut Medical School; Hartford, CT

40. Nov 11-14, 1971; Hilton Hotel; Washington Hospital Center; Washington, DC (Clinical Pathology of the Serum Lipids)

41. April 27-30, 1972; Holiday Inn; Notre Dame University; Ames Co; Elkhart, IN

42. Nov 2-5, 1972; Marriott Motor Hotel; Northwestern University Medical School; Chicago, IL (Clinical Pathology of Respiratory Diseases)

43. May 3-5, 1973; Hawaiian Village Motel; St Joseph’s Hospital; University of South Florida College of Medicine; Tampa, FL

44. Nov 2-4, 1973; Shoreham Hotel; Washington Hospital Center; Washington, DC (Laboratory Diagnosis of Cancer)

45. March 7-10, 1974; La Jolla Village Inn; Scripps Foundation; University of California Medical School; La Jolla, CA

46. Nov 8-10, 1974; Bellevue-Stratford Hotel; Thomas Jefferson Medical College; Philadelphia, PA (Laboratory Diagnosis of Skeletal, Muscular, and Neurological Disorders)

47. May 2-4, 1975; Governors Inn; University of North Carolina Medical School; Chapel Hill, NC

48. Nov 7-9, 1975; Bellevue-Stratford Hotel; Thomas Jefferson Medical School; Philadelphia, PA (Laboratory Diagnosis and Monitoring of Disorders Caused by Drugs and Toxic Agents)

49. April 21-25, 1976; Hyatt Hotel; University of Puerto Rico Medical School; San Juan, PR

50. Nov 5-7, 1976; Shoreham Hotel, Washington, DC (Clinical Enzymology)

51. March 2-5, 1977; Congress Centre, Monte Carlo, Monaco (International Symposium on Clinical Chemistry and Chemical Toxicology of Metals)

52. April 28-May 1, 1977; Christopher Inn; Battelle Columbus Labs; Ohio State University School of Medicine; Columbus, OH

53. Nov 11-13, 1977; Drake Hotel, Northwestern University Medical School; Chicago, IL (Proteins and Proteinopathies)

54. May 4-7, 1978; Fairmont Hotel; University of California Medical School; San Francisco, CA

55. May 22-24, 1978; Caledonian Hotel; Falconbridge Nikkelwerk; Kristiansand, Norway (Kristiansand Conference on Nickel Toxicology)

56. Nov 3-5, 1978; Shoreham Hotel, Washington, DC (Clinical Pathology of Cancer of the Endocrine Glands and Target Organs)

57. May 3-6, 1979; Mills-Hyatt House; Medical University of South Carolina; Charleston, SC

58. Oct. 11-14, 1979; Benjamin Franklin Hotel; Jefferson Medical College; Philadelphia, PA (Biochemical Hematology)

59. May 8-11, 1980; Colonnade Hotel; Harvard Medical School; Boston, MA

60. Sept 3-5, 1980; Dragon Hotel; University College of Swansea; Swansea, Wales, United Kingdom (Swansea Conference on Nickel Toxicology)

61. Oct 31-Nov. 2, 1980; Drake Hotel, Chicago, IL (Laboratory Diagnosis and Monitoring of Disorders of the Kidney)

62. May 7-10, 1981; Bay Harbor Inn; St Joseph’s Hospital; University of South Florida College of Medicine; Tampa, FL

63. Oct 29-Nov 1, 1981; Barclay Hotel, Philadelphia, PA (Diagnosis of Disorders of the Fetus, Newborn, and Infant)

64. May 6-9, 1982; Sheraton-Miramar Hotel; UCLA Medical School; Beckman Instruments, Inc; Santa Monica, CA

65. June 17-20, 1982; Hotel Vier Jahreszeiten, Munich, Federal Republic of Germany (International Conference on Human Tumor Markers)

66. Nov 11-13, 1982; Drake Hotel, Chicago, IL (Laboratory Diagnosis and Monitoring of Cancer)

67. May 12-15, 1983; Boar’s Head Inn; University of Virginia Medical Center; Charlottesville, VA

68. July 19-22, 1983; Sheraton Centre, Montreal, Canada (Second International Conference on Clinical Chemistry and Chemical Toxicology of Metals)

69. Nov 10-13, 1983; Shoreham Hotel, Washington, DC (Clinical Pathology of Liver and Biliary Tract)

70. Feb 20-22, 1984; Hilton Hotel, Vienna, Austria (Second International Congress on Human Tumor Markers)

71. May 3-6, 1984; Hilton Hotel; University of South Alabama Medical School; Mobile, AL

72. Sept 4-7, 1984; PLM-St Jacques Hotel; Société Le Nickel; Paris, France (Nickel Metabolism and Toxicology)

73. Nov 15-18, 1984; Barclay Hotel, Philadelphia, PA (Clinical Pathology of the Reproductive Systems)

74. May 9-12, 1985; Sheraton-Islander Hotel; Brown University Medical School; Newport, RI

75. Oct 9-13, 1985; Galt House Hotel; Audubon Hospital; Louisville, KY (Diagnosis of Cardiovascular Disorders)

76. April 23-26, 1986; Ischia, Italy (Third International Conference on Human Tumor Markers)

77. May 15-18, 1986; Excelsior Hotel; University of Arkansas Medical School; Little Rock, AR

78. July 28-Aug 1, 1986; University of Occupational and Environmental Health, Kitakyushu, Japan (Third International Conference on Clinical Chemistry and Chemical Toxicology of Metals)

79. Nov 13-16, 1986; Colony Square Hotel; Emory University School of Medicine; Atlanta, GA (Nucleic Acid Probes and Monoclonal Antibodies in Human Disease)

80. May 14-17, 1987; The Charleston Place Hotel; Medical University of South Carolina; Charleston, SC

81. Aug 17-21, 1987; Odense University, Denmark (Symposium on Trace Elements in Human Health & Disease)

82. Aug 25-28, 1987; Omni Park Hotel, New York, NY (Fourth International Conference on Human Tumor Markers)

83. Nov 12-15, 1987; Lincoln Hotel, Tampa, FL (Applied Seminar on Analytical and Clinical Toxicology)

84. May 12-15, 1988; Newporter Resort; UCLA Medical School; Beckman Instruments; Newport Beach, CA

85. May 29-June 3, 1988; Brioni Hotel, Brioni, Yugoslavia (Symposium on Drugs in Competitive Athletics)

86. Sept 5-9, 1988; Hanasaari Centre, Helsinki, Finland (Fourth International Conference on the Metabolism and Toxicology of Nickel)

87. Sept 19-23, 1988; Stockholm, Sweden (Fifth International Conference on Human Tumor Markers)

88. Nov 10-13, 1988; Parkview-Hilton Hotel, Hartford, CT; University of Connecticut Medical School, Farmington, CT (Applied Seminar on Hematology)

89. May 11-14, 1989; Omni Hotel; University of Virginia Medical School; Charlottesville, VA

90. May 23-26, 1989; Miyako Hotel, Tokyo, Japan (Sixth International Conference on Human Tumor Markers)

91. November 16-19, 1989; Hershey Hotel, Philadelphia, PA (Applied Seminar on Laboratory Diagnosis of Liver Diseases)

92. May 10-13, 1990; Meridien Hotel; University of British Columbia Faculty of Medicine; Vancouver, BC, Canada

93. June 5-8, 1990; Hanasaari Centre, Espoo, Helsinki, Finland (Fourth International Symposium on Trace Elements in Health and Disease)

94. September 10-14, 1990; Hotel Rus, Kiev, Russia (Seventh International Conference on Human Tumor Markers)

95. November 7-11, 1990; Clarion Hotel; University of Cincinnati Medical School; Cincinnati, OH (The Laboratory Diagnosis of Disorders of the Fetus, Newborn, and Early Childhood)

96. May 8-12, 1991; Red Lion Hotel; University of Utah Medical School; Salt Lake City, UT

97. September 9-12,1991; Triaena Congress Centre, Athens, Greece (International Congress on Immunoenzymatic Techniques)

98. November 14-17, 1991; Omni Hotel, Jacksonville, FL (Six Major Advances in Laboratory Diagnosis and Clinical Applications)

99. May 13-17, 1992; Sheraton University Inn; Medical School of the State University of New York; Syracuse, NY

100. Sept 6-10, 1992; Vienna, Austria (Ninth International Conference on Human Tumor Markers)

101. Nov 11-15, 1992; Red Lion Resort; Sansum Medical Foundation; Santa Barbara, CA (Laboratory Diagnosis of Metabolic Disorders, Emphasizing Diabetes Mellitus)

102. May 12-16, 1993; Newport Islander Doubletree Hotel; Brown University Medical School; Newport, RI

103. Sept 6-10, 1993; Bonn, Germany (Tenth International Conference on Human Tumor Markers)

104. Nov 3-7, 1993; Hilton Hotel; Medical College of Ohio; Toledo, OH (Advances in the Laboratory Diagnosis of Cancer)

105. May 11-15, 1994; Lodge Alley Inn; Medical University of South Carolina; Charleston, SC

106. Nov 16-20, 1994; Holiday Inn Crowne Plaza; University of South Florida College of Medicine; Tampa, FL (Clinical Science of Ageing)

107. May 10-14, 1995; Houston Plaza Hilton Hotel; MD Anderson Cancer Center; University of Texas School of Medicine; Houston, TX

108. June 11-14, 1995; New York Hilton, New York, NY (Twelfth International Conference on Human Tumor Markers)

109. July 10-13, 1995; University of British Columbia, Vancouver, Canada (Fifth International Symposium on Toxicology & Clinical Chemistry of Metals)

110. Oct 25-29 1996; Holiday Inn Crowne Plaza, Redondo Beach, CA (Immunologic Techniques for Diagnosis, Transplantation, and Therapy)

111. May 1-5, 1996; Carolina Inn; University of North Carolina Medical School; Chapel Hill, NC

112. June 16-19, 1996; Shangri-La Hotel, Singapore (Thirteenth International Conference on Human Tumor Markers)

113. Oct 30 - Nov 3 1996; Seelbach Hotel; University of Louisville Medical School; Louisville, KY (Neurologic and Psychiatric Diseases: Molecular Basis and Diagnostic Approaches)

114. May 7-11, 1997; University Park Hotel; University of Utah School of Medicine; ARUP Laboratories; Salt Lake City, UT

115. November 5-9, 1997; Emory Conference Hotel; Emory University School of Medicine; Atlanta, GA (Laboratory Diagnosis of Infectious Diseases)

116. April 29 - May 3, 1998; Biltmore Hotel; Brown University School of Medicine; Providence, RI

117. October 21-23, 1998; Doubletree Hotel; Jefferson Medical College; Philadelphia, PA (Clinical Science in the New Millennium)

118. October 5-9, 1999; Fawcett Center Hotel; Ohio State University Medical School; Columbus, OH

119. Nov 3-7, 1999; Radisson Hotel La Jolla; University of California at San Diego; Scripps Research Institute; La Jolla, CA (Molecular and Clinical Immunology and Immunopathology)

120. May 17-20, 2000; Partridge Inn; Medical College of Georgia; Augusta, GA Hemoglobinopathies)

121. May 9-12, 2001; The Carolina Inn; The University of North Carolina School of Medicine; Chapel Hill, NC (Applications of Molecular Biology in Laboratory Diagnosis)

122. May 8-11, 2002; Hotel Monaco; The University of Utah School of Medicine; ARUP Laboratories, Salt Lake City, UT (Sports Medicine, Fitness Training, and Related Topics)

123. May 7-11, 2003; TradeWinds Resort, University of South Florida College of Medicine; University of Tampa, St Petersburg, FL (Metabolic Diseases)

124. May 12-16, 2004; Warwick Hotel; University of Texas College of Medicine; The M.D. Anderson Cancer Center; Houston, TX (Infectious Diseases and Pulmonary Pathology; Informatics in Pathology and Laboratory Medicine)

125. May 11-15, 2005; Somerset Inn; William Beaumont Hospital, Troy and Royal Oak, MI (Diagnostic Applications of Molecular Biology)

126. May 17-21, 2006; Amelia Island Plantation Resort and University of Florida Medical School, Amelia Island (Diseases of the Reproductive Organs; Prevention of Medical Errors)

127. May 16-20, 2007; Hershey Lodge Conference Center, Penn State University Medical School, Geisinger Medical Center, Hershey and Danville, PA (Workshop on Proteomics in Cancer Therapy)

128. May 14-18, 2008; Marina del Mar Hotel and UCLA Medical School, Los Angeles, CA (Symposium on Solid Organ Transplantation)

129. May 13-17 2009; Embassy Suites Hotel; University of South Florida College of Medicine and the University of Tampa, Tampa, FL

130. May 12-16, 2010; St Anthony Hotel; University of Texas Health Science Center, San Antonio, TX (Transfusion Medicine)

131. May 18-22, 2011; Seelbach Hilton Hotel; University of Louisville School of Medicine; Louisville KY (Personalized Medicine and Genomics)

132. May 23-27, 2012; Renaissance Mobile Riverview Plaza Hotel; University of South Alabama School of Medicine; Mobile, AL (Advances in Pathology for Personalized Medicine)

133. May 22-25, 2013; Omni Parker House Hotel; Harvard Vanguard Medical Associates; Boston, MA (Advances in Molecular / Genetic Diagnostics and Pediatric Pathology)

134. May 28-31, 2014; Omni Amelia Island Plantation Resort; the Blood Alliance and University of Florida College of Medicine, Jacksonville, FL (Frontiers in Transfusion Medicine)

135. May 13-16, 2015; Little America Hotel, Salt Lake City, UT, the University of Utah Department of Pathology and ARUP Laboratories, (Clinical; Applications of Next Generation Technologies)

136. May 4-7, 2016, Arlington Hotel & Spa, Hot Springs, Arkansas, University of Arkansas for Medical Sciences (Diagnosis, Prognosis, and Monitoring of Multiple Myeloma)

137. May 17-20, 2017, Grand Bohemian Hotel, Birmingham, AL, the University of Alabama at Birmingham Department of Pathology, (Disruptive Innovations in Clinical and Anatomic Pathology and Advancing the Role of Laboratory Medicine in Preventing Diagnostic Error)